Literature DB >> 11991968

Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2.

Yi Fu1, Keiko Kumura Ishii, Yasuhiko Munakata, Takako Saitoh, Mitsuo Kaku, Takeshi Sasaki.   

Abstract

Human parvovirus B19 frequently causes acute and chronic arthritis in adults. The molecular mechanism of B19 arthritis, however, remains poorly understood. We previously showed that the transmission of B19 from rheumatoid synoviocytes to monocytic cells is associated with enhanced secretion of tumor necrosis factor alpha (TNF-alpha), which triggers inflammation, and interleukin-6. To determine the role of B19 in the production of TNF-alpha, we focused on the function of its nonstructural protein, NS1, and established monocytic U937 lines transduced with the NS1 gene under the control of an inducible promoter. Production of TNF-alpha mRNA and protein was elevated in a manner associated with NS1 expression. Reporter assays revealed that AP-1 and AP-2 motifs on the TNF-alpha promoter were responsible for NS1-mediated up-regulation. Electrophoretic mobility shift assay showed specific binding of nuclear proteins from NS1 gene-transduced cells with the AP-1 or AP-2 probe. Antibodies against transcription factors AP-1 and AP-2 and anti-NS1 antibody inhibited the binding of nuclear proteins to the corresponding probes. These data indicate that NS1 up-regulates TNF-alpha transcription via activation of AP-1 and AP-2 in monocytic cells. The molecular mechanisms of NS1-mediated TNF-alpha expression would explain the pathogenesis of B19-associated inflammation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11991968      PMCID: PMC137035          DOI: 10.1128/jvi.76.11.5395-5403.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Chronic bone marrow failure due to persistent B19 parvovirus infection.

Authors:  G J Kurtzman; K Ozawa; B Cohen; G Hanson; R Oseas; N S Young
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

2.  Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis.

Authors:  R O Shade; M C Blundell; S F Cotmore; P Tattersall; C R Astell
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

3.  B19 parvovirus replicates in circulating cells of acutely infected patients.

Authors:  G J Kurtzman; P Gascon; M Caras; B Cohen; N S Young
Journal:  Blood       Date:  1988-05       Impact factor: 22.113

4.  B19 parvovirus infection of myocardial cells.

Authors:  H J Porter; A M Quantrill; K A Fleming
Journal:  Lancet       Date:  1988-03-05       Impact factor: 79.321

5.  Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors.

Authors:  J Yao; N Mackman; T S Edgington; S T Fan
Journal:  J Biol Chem       Date:  1997-07-11       Impact factor: 5.157

6.  Human parvovirus infection in early rheumatoid and inflammatory arthritis.

Authors:  B J Cohen; M M Buckley; J P Clewley; V E Jones; A H Puttick; R K Jacoby
Journal:  Ann Rheum Dis       Date:  1986-10       Impact factor: 19.103

7.  Clinical manifestations of human parvovirus B19 in adults.

Authors:  A D Woolf; G V Campion; A Chishick; S Wise; B J Cohen; P T Klouda; O Caul; P A Dieppe
Journal:  Arch Intern Med       Date:  1989-05

8.  Human granulocyte-macrophage colony-stimulating factor induces expression of the tumor necrosis factor gene by the U937 cell line and by normal human monocytes.

Authors:  S A Cannistra; A Rambaldi; D R Spriggs; F Herrmann; D Kufe; J D Griffin
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

9.  Human parvovirus arthropathy.

Authors:  D G White; A D Woolf; P P Mortimer; B J Cohen; D R Blake; P A Bacon
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

10.  Experimental parvoviral infection in humans.

Authors:  M J Anderson; P G Higgins; L R Davis; J S Willman; S E Jones; I M Kidd; J R Pattison; D A Tyrrell
Journal:  J Infect Dis       Date:  1985-08       Impact factor: 5.226

View more
  30 in total

1.  Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors.

Authors:  Zhihong Wan; Ning Zhi; Susan Wong; Keyvan Keyvanfar; Delong Liu; Nalini Raghavachari; Peter J Munson; Su Su; Daniela Malide; Sachiko Kajigaya; Neal S Young
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

2.  The human parvovirus B19 non-structural protein 1 N-terminal domain specifically binds to the origin of replication in the viral DNA.

Authors:  Sunil Kumar Tewary; Haiyan Zhao; Xuefeng Deng; Jianming Qiu; Liang Tang
Journal:  Virology       Date:  2013-12-20       Impact factor: 3.616

3.  Apoptosis of liver-derived cells induced by parvovirus B19 nonstructural protein.

Authors:  Brian D Poole; Jing Zhou; Amy Grote; Adam Schiffenbauer; Stanley J Naides
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

4.  The potential role of human endogenous retrovirus K10 in the pathogenesis of rheumatoid arthritis: a preliminary study.

Authors:  H D Ejtehadi; G L Freimanis; H A Ali; S Bowman; A Alavi; J Axford; R Callaghan; P N Nelson
Journal:  Ann Rheum Dis       Date:  2005-09-28       Impact factor: 19.103

5.  Parvovirus infection-induced DNA damage response.

Authors:  Yong Luo; Jianming Qiu
Journal:  Future Virol       Date:  2013-03-01       Impact factor: 1.831

6.  Gender differences in the relationship of anti-parvovirus B19 IgG with antinuclear antibody and C-reactive protein in clinical adult serum samples.

Authors:  Thomas A O'Bryan; Stanley J Naides
Journal:  Rheumatol Int       Date:  2009-12-13       Impact factor: 2.631

7.  Human parvovirus B19 nonstructural protein NS1 enhanced the expression of cleavage of 70 kDa U1-snRNP autoantigen.

Authors:  Bor-Show Tzang; Der-Yuan Chen; Chun-Chou Tsai; Szu-Yi Chiang; Tsung-Ming Lin; Tsai-Ching Hsu
Journal:  J Biomed Sci       Date:  2010-05-25       Impact factor: 8.410

8.  Parvovirus b19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease.

Authors:  Loris Pironi; Francesca Bonvicini; Paolo Gionchetti; Antonia D'Errico; Fernando Rizzello; Catia Corsini; Laura Foroni; Giorgio Gallinella
Journal:  J Clin Microbiol       Date:  2009-03-11       Impact factor: 5.948

9.  Increased expression and secretion of interleukin-6 in human parvovirus B19 non-structural protein (NS1) transfected COS-7 epithelial cells.

Authors:  T-C Hsu; B-S Tzang; C-N Huang; Y-J Lee; G-Y Liu; M-C Chen; G J Tsay
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

10.  Human parvovirus B19 DNA replication induces a DNA damage response that is dispensable for cell cycle arrest at phase G2/M.

Authors:  Sai Lou; Yong Luo; Fang Cheng; Qinfeng Huang; Weiran Shen; Steve Kleiboeker; John F Tisdale; Zhengwen Liu; Jianming Qiu
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.